Document Detail


Pathophysiology of hemodialysis-associated hypoxemia.
MedLine Citation:
PMID:  2493719     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The dialysis patient treated intermittently on a three-times-weekly schedule is exposed during the short dialysis period (4 hours) to abrupt changes in the internal milieu. During the 44 hours of the interdialytic period, H+ ions accumulate slowly, causing respiratory-compensated (hyperventilation) metabolic acidosis in the patient at the start of dialysis. The arterial bicarbonate concentration (HCO3-) is between 17 and 23 mEq/L and a relatively low arterial carbon dioxide tension (PaCO2) of 33-36 mm Hg is observed. Four hours later, after exposure to a biocompatible (polyacrylonitrile) or bioincompatible membrane (cuprophane) and a bicarbonate or acetate dialysis bath, the patient reaches metabolic alkalosis after mild to moderate hypoventilation, with or without breathing irregularities. Defined another way, the dialysis patient is an acid accumulator for 44 hours, after which a 4-hour period of efficient retitration occurs that is accompanied by a variable degree of hypoxemia. The latter phenomenon has been the subject of numerous investigations during the past 10 years. As happens with complex biologic processes, the conclusions reached by the various investigators are conflicting, depending on their viewpoint and the variables they examined. Since Sherlock in 1977 showed that patients dialyzed with an acetate-containing dialysate became hypoxemic and attributed it to hypoventilation after carbon dioxide (CO2) losses through the dialyzer, a number of other mechanisms have been proposed, defended by some and questioned by others. The purpose of this short overview is to evaluate critically the various proposed mechanisms, showing the minor role played by some and defining the respective roles of the two principal mechanisms, i.e., CO2 unloading, and the complement activation-hypoxemia cascade.
Authors:
M E De Broe; W A De Backer
Related Documents :
6105349 - Dialysis dementia in europe. report from the registration committee of the european dia...
19889239 - Lack of association between mutations of gene-encoding mitochondrial d310 (displacement...
18209439 - Spectrum of tuberculosis in dialysis patients in saudi arabia.
1067489 - Dialysate calcium levels, dialysis hours and the healing of osteitis fibrosa.
20176609 - Fibroblast growth factor-23 (fgf-23) is independently correlated to aortic calcificatio...
11800089 - Treatment of systemic inflammatory response syndrome by push-pull powdered sorbent pher...
1160759 - The tourist as patient.
6476229 - Negative findings at appendectomy.
9212589 - Management of poor-grade patients with ruptured intracranial aneurysm.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Advances in nephrology from the Necker Hospital     Volume:  18     ISSN:  0084-5957     ISO Abbreviation:  Adv. Nephrol. Necker Hosp.     Publication Date:  1989  
Date Detail:
Created Date:  1989-04-19     Completed Date:  1989-04-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0311622     Medline TA:  Adv Nephrol Necker Hosp     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  297-315     Citation Subset:  IM    
Affiliation:
Department of Nephrology-Hypertension, University of Antwerp, University Hospital, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetates / metabolism
Anoxia / etiology,  physiopathology*
Carbon Dioxide / metabolism
Complement Activation
Humans
Pulmonary Gas Exchange
Renal Dialysis / adverse effects*
Chemical
Reg. No./Substance:
0/Acetates; 124-38-9/Carbon Dioxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Will the "short dialysis" of the eighties be adequate?
Next Document:  Transplantation in hyperimmunized patients.